Project 461314
Role for defective enhancer commissioning in the hypotonia phenotype of Kabuki Syndrome patients
Role for defective enhancer commissioning in the hypotonia phenotype of Kabuki Syndrome patients
Project Information
| Study Type: | Unclear |
| Research Theme: | Biomedical |
Institution & Funding
| Principal Investigator(s): | Dilworth, F J |
| Institution: | Ottawa Hospital Research Institute |
| CIHR Institute: | Genetics |
| Program: | |
| Peer Review Committee: | Genetics |
| Competition Year: | 2022 |
| Term: | 5 yrs 0 mth |
Abstract Summary
This research project that uses genetic mouse models of the epigenetic enzymes MLL4 and UTX to determine how mutations in these genes give rise to muscle weakness (hypotonia) in children with Kabuki Syndrome. We have characterized mice with mutations in each of these proteins, and found that the muscle stem cells responsible for building and repairing the muscle are very inefficient at generating new muscle fibres. We are exploiting these mouse systems to identify the mechanisms disrupted in these stem cells that prevent efficient repair of the muscle. Thus, the knowledge gained from these studies will be important to the development of new therapies to treat hypotonia in Kabuki Syndrome. Furthermore, as Kabuki Syndrome is a multi-system disease that remains poorly understood for all affected tissues, our strong muscle phenotype observed in mutant mice will allow us to provide the first insight into the disease mechanism with the hope it will help understand the disease progression in other tissues.
No special research characteristics identified
This project does not include any of the advanced research characteristics tracked in our database.